SI
BVS icon

Stephens Inc’s Bioventus BVS Stock Holding History

Stephens Inc’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,975
Closed -$110K – 1284
2025
Q1 		$110K Sell
11,975
-14,800
-55% -$148K ﹤0.01% 1172
2024
Q4 		$281K Sell
26,775
-28,925
-52% -$342K ﹤0.01% 1045
2024
Q3 		$666K Sell
55,700
-28,325
-34% -$245K 0.01% 728
2024
Q2 		$483K Sell
84,025
-31,800
-27% -$174K 0.01% 813
2024
Q1 		$602K Sell
115,825
-26,850
-19% -$131K 0.01% 737
2023
Q4 		$752K Sell
142,675
-8,800
-6% -$34.8K 0.01% 608
2023
Q3 		$500K Sell
151,475
-121,121
-44% -$425K 0.01% 726
2023
Q2 		$788K Sell
272,596
-37,225
-12% -$71.4K 0.01% 605
2023
Q1 		$332K Sell
309,821
-29,605
-9% -$56.6K 0.01% 847
2022
Q4 		$886K Sell
339,426
-24,225
-7% -$106K 0.02% 531
2022
Q3 		$2.55M Buy
363,651
+22,750
+7% +$178K 0.05% 321
2022
Q2 		$2.33M Buy
340,901
+106,555
+45% +$1.09M 0.05% 340
2022
Q1 		$3.3M Buy
234,346
+49,760
+27% +$666K 0.05% 333
2021
Q4 		$2.67M Buy
+184,586
New +$2.62M 0.04% 393

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Stephens Inc's BVS Position: Q2 2025 in Review

Stephens Inc sold out of Bioventus (BVS) in Q2 2025, closing a stake of 11,975 shares — an estimated $110K sold.

Stephens Inc first reported a position in BVS in Q4 2021 and held it in 14 quarters. The position peaked at $3.3M in Q1 2022. 134 funds tracked by Wall St. Rank hold BVS as of Q2 2025.

  • Stephens Inc reported no remaining Bioventus position as of Q2 2025 after selling out during the quarter.
  • Stephens Inc sold 11,975 Bioventus shares in Q2 2025, an estimated $110K.
  • Stephens Inc first reported a position in Bioventus in Q4 2021 and held it in 14 quarters.
  • Stephens Inc's Bioventus position peaked at $3.3M in Q1 2022.
  • 134 funds tracked by Wall St. Rank held Bioventus as of Q2 2025.

Based on Stephens Inc's 13F filing for Q2 2025, filed 29 Jul 2025.